Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCHE | P06276 | 8/20 | 0.49 |
| ▸ | ACHE | P22303 | 7/20 | 0.49 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.48 |
| ▸ | MCHR1 | Q99705 | 2/20 | 0.48 |
| ▸ | SLC6A9 | P48067 | 4/20 | 0.46 |
| ▸ | ESR1 | P03372 | 1/20 | 0.42 |
| ▸ | MAOA | P21397 | 1/20 | 0.42 |
| ▸ | MAOB | P27338 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4856388 | 1.00 | BCHE (0.49) | BCHEACHESLC2A1MCHR1SLC6A9 | |
| SCHEMBL3684938 | 0.90 | ABCG2 (0.48) | BCHEACHESLC2A1MCHR1 | |
| SCHEMBL3690153 | 0.90 | ABCG2 (0.48) | BCHEACHESLC2A1MCHR1 | |
| SCHEMBL4853606 | 0.90 | SYK (0.47) | BCHEACHESLC2A1MCHR1MAOA | |
| SCHEMBL4847745 | 0.90 | SYK (0.47) | BCHEACHESLC2A1MCHR1MAOA | |
| SCHEMBL4848110 | 0.87 | BCHE (0.51) | BCHEACHESLC2A1MCHR1SLC6A9 | |
| SCHEMBL4853434 | 0.87 | BCHE (0.51) | BCHEACHESLC2A1MCHR1SLC6A9 | |
| SCHEMBL4849159 | 0.85 | BCHE (0.54) | BCHEACHESLC2A1SLC6A9ESR1 | |
| SCHEMBL4852436 | 0.85 | BCHE (0.54) | BCHEACHESLC2A1SLC6A9ESR1 | |
| SCHEMBL4853801 | 0.84 | MCHR1 (0.53) | BCHEACHEMCHR1SLC6A9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7423181-B2 | in particular against bacterial and parasitic infections, fungi, and helminths; improved metabolic and physiochemical properties, bioavailability, solubility; 3-[4-(2-Dimethylamino-ethoxy)-2'-trifluoromethyl-biphenyl-3-yl]-1-(2-dimethylaminomethyl-phenyl)-propenone | LICA PHARMACEUTICALS A/S (DK) | 2008-09-09 | — | — | US | disclosed |
| US-20050227990-A1 | Aminoalkoxy-functional chalcones | LICA PHARMACEUTICALS A/S (DK) | 2005-10-13 | — | — | US | disclosed |